Hualan Biological Vaccine Inc. (SHE:301207)
China flag China · Delayed Price · Currency is CNY
19.38
-0.39 (-1.97%)
Apr 21, 2026, 3:04 PM CST

Hualan Biological Vaccine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
11,76311,08510,41816,68017,832-
Market Cap Growth
13.88%6.40%-37.54%-6.46%--
Enterprise Value
8,9788,0098,18014,34615,905-
Last Close Price
19.7718.6316.8025.8227.44-
PE Ratio
64.3160.6050.6919.4034.32-
Forward PE
54.927.759.8615.22--
PS Ratio
9.789.229.246.929.77-
PB Ratio
2.061.941.732.663.24-
P/TBV Ratio
2.071.951.742.673.26-
P/FCF Ratio
33.8631.9125.0220.2190.98-
P/OCF Ratio
32.9431.0422.2618.7861.78-
EV/Sales Ratio
7.476.667.255.958.71-
EV/EBITDA Ratio
38.8134.6234.8114.0324.91-
EV/EBIT Ratio
99.4788.7386.4316.2731.55-
EV/FCF Ratio
25.8423.0519.6417.3881.14-
Debt / Equity Ratio
--0.050.050.060.18
Debt / EBITDA Ratio
--1.280.290.470.68
Debt / FCF Ratio
--0.720.361.53-
Net Debt / Equity Ratio
-0.49-0.49-0.49-0.37-0.34-0.16
Net Debt / EBITDA Ratio
-12.04-12.04-12.45-2.26-2.90-0.61
Net Debt / FCF Ratio
-8.02-8.02-7.03-2.80-9.436.82
Asset Turnover
0.170.170.140.320.320.45
Inventory Turnover
1.681.681.502.242.694.64
Quick Ratio
3.703.703.192.732.571.43
Current Ratio
3.923.923.403.102.731.51
Return on Equity (ROE)
3.12%3.12%3.35%14.63%12.51%24.86%
Return on Assets (ROA)
0.78%0.78%0.76%7.32%5.43%10.28%
Return on Invested Capital (ROIC)
3.19%2.93%2.58%19.83%14.81%30.53%
Return on Capital Employed (ROCE)
1.60%1.60%1.60%14.00%9.10%23.60%
Earnings Yield
1.56%1.65%1.97%5.16%2.91%-
FCF Yield
2.95%3.13%4.00%4.95%1.10%-
Dividend Yield
8.04%7.51%1.19%2.32%0.73%-
Payout Ratio
277.66%277.66%162.67%13.95%17.49%2.06%
Buyback Yield / Dilution
0.51%0.51%0.71%-2.03%-9.33%-0.01%
Total Shareholder Return
8.55%8.03%1.91%0.29%-8.61%-0.01%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.